Abstract: The application provides a preparation method and use of a diatom-bacterium symbiotic organic liquid fertilizer, and belongs to the technical field of biological fertilizers. The preparation method of the diatom-bacterium symbiotic organic liquid fertilizer includes the following steps: (1) mixing a compound bacterial powder with a waste liquid organic matter to allow first fermentation to obtain a small-molecule organic liquid fertilizer; (2) mixing diatom with the small-molecule organic liquid fertilizer to allow second fermentation to obtain a bio-organic fertilizer; and (3) mixing a microbial inoculant with the bio-organic fertilizer to allow third fermentation to obtain the diatom-bacterium symbiotic organic liquid fertilizer. In the application, the diatom-bacterium symbiotic organic liquid fertilizer prepared by the preparation method is used for soil improvement.

Abstract: Disclosed are a hydraulic fracturing and cutting cooperative device suitable for a hard rock and a use method thereof, belonging to the technical field of high-efficiency and rapid excavation of hard rock roadway (tunnel). The hydraulic fracturing and cutting cooperative device suitable for a hard rock provided by the disclosure includes a drill pipe, a pneumatic drilling system, a hydraulic fracturing system, a collaborative control system and a cutting head.

Abstract: Disclosed are techniques for positioning. A receiver receives complementary timing information associated with the positioning reference signals (PRS) of a repetition of a PRS sequence. The complementary timing information distinguishes a repetition of a PRS sequence from remaining repetitions of the PRS sequence. Based on the complementary timing information associated with different PRS from different non-terrestrial vehicles indicating that the PRS were transmitted during the same radio frame, the receiver can determine an observed time difference of arrival (OTDOA) between the PRS received from the respective non-terrestrial vehicles.

Abstract: Methods, systems, and devices for wireless communications are described. A UE may determine a set of resources available for transmission of one or more reference signals (e.g., one or more PRSs) in a shared radio frequency spectrum band (e.g., an unlicensed radio frequency spectrum band) in a time interval for sidelink positioning. The UE may transmit, in a second radio frequency spectrum, a control message reserving the set of resources for the UE to transmit the one or more reference signals in the time interval for sidelink positioning. The UE may transmit the one or more reference signals on the set of resources based on transmitting the control message reserving the set of resources.

Abstract: Disclosed are a zirconium-based metal-organic framework material and a preparation method thereof. Plasma-activated water or strong acid electrolyzed water is added to a raw material system for preparing a zirconium-based metal-organic framework material UiO-66, and they are then subjected to a reaction to obtain a crude product. The crude product is subjected to a post-treatment to obtain the zirconium-based metal-organic framework material UiO-66.

Abstract: A method for 3D oscillating-gradient prepared gradient spin-echo imaging and a device. The imaging method comprises the following steps: first, using a global saturation module to destroy previous residual transverse magnetization; second, embedding a pair of trapezoidal cosine oscillating gradients into a 90°x-180°y-90°?x radiofrequency pulse by a diffusion encoding module, to separate diffusion encoding from signal acquisition; then, using a fat saturation module to suppress a fat signal; finally, acquiring a signal by means of gradient spin-echo readout, and correcting phase errors among multiple excitations by multiplexed sensitivity-encoding reconstruction. Compared with a 2D plane echo-based oscillating gradient diffusion sequence used on a 3T clinical system, a 3D oscillating-gradient prepared gradient spin-echo sequence effectively reduces the imaging time, improves the signal to noise ratio, and is beneficial to clinical transformation of time-dependent diffusion MRI technology.

Abstract: The present invention pertains to methods of coating antimicrobial peptides on the biomaterial and the biomaterial coated thereby. The coating solution described herein comprises one or more antimicrobial peptides (AMPs) dissolved in a buffer containing an anionic surfactant, wherein the AMPs are amphipathic and cationic.

Abstract: This disclosure provides systems, devices, apparatus, and methods, including computer programs encoded on storage media, for prioritization of sidelink-based positioning transmissions. A first UE may receive a request to initiate a sidelink positioning session with a second UE for which a sidelink positioning transmission will overlap in a time domain with communication between the first UE and a base station over a Uu access link. The first UE may transmit the sidelink positioning transmission if a first priority level of the sidelink positioning transmission is higher than a second priority level of the communication over the Uu access link. The first UE may adjust transmission of the sidelink positioning transmission if the first priority level of the sidelink positioning transmission is not higher than the second priority level of the communication over the Uu access link.

Abstract: A user equipment (UE) may include a main radio (MR) and a Low Power Wake-Up Radio (LR). The UE may coordinate periods where the MR and LR are on and off. For example, the UE may enter a deep sleep state by turning off a main radio (MR) of the UE, and turning on a Low Power Wake-Up Radio (LR) of the UE. The MR may receive an event indication from the LR to turn on the MR. The MR may turn on and perform a procedure according to an event corresponding to the event indication.

Abstract: Systems, methods, and software described herein provide enhancements for managing permissions in a shared graph. In one implementation, a graph management system identifies a request to classify a first subgraph in the graph for access by a tenant of a plurality of tenants, wherein the request indicates one or more vertex types and/or one or more edge types for the first subgraph. The graph management system further identifies one or more vertices and/or one or more edges in the graph that qualify for the first subgraph based on the indicated one or more vertex types and/or one or more edge types, and allocates permissions to at least one user associated with the tenant to access the first subgraph.

Abstract: The present disclosure provides an image processing method, a computing system, a device, and a readable storage medium. The image processing method includes: using an inverse tone mapping neural network to process a first image, the inverse tone mapping neural network is configured to expand a dynamic range of the first image and a color gamut range of the first image to obtain a second image that is expanded, the inverse tone mapping neural network includes a mapping network, the mapping network is used to realize the expansion, and the inverse tone mapping neural network further includes an attention network, an input of the mapping network and an input of the attention network are both the first image, the attention network is used to process image contents of the first image to generate correction coefficients, and the correction coefficients are used to correct parameters of the mapping network.

Abstract: This invention relates to the use of (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino) pyridin-3-yl]methanone (NSI-189) or a pharmaceutically acceptable salt thereof in the treatment of a psychiatric condition in which depressive symptoms are prominent, including major depressive disorder, bipolar disorder, posttraumatic stress disorder, substance use disorder, and depression-related aspects of schizophrenia (e.g. negative symptoms), in a patient who is cognitively impaired or has poor or slow cognition or difficulty making decisions or exhibits certain EEG properties. The present invention also relates to the selection of patients with a biomarker (e.g., EEG) and/or clinical symptoms who would most benefit from such compounds.

Abstract: This invention relates to the use of (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone (NSI-189) or a pharmaceutically acceptable salt thereof in the treatment of a psychiatric condition in which depressive symptoms are prominent, including major depressive disorder, bipolar disorder, posttraumatic stress disorder, substance use disorder, and depression-related aspects of schizophrenia (e.g. negative symptoms), in a patient who is cognitively impaired or has poor or slow cognition or difficulty making decisions or exhibits certain EEG properties. The present invention also relates to the selection of patients with a biomarker (e.g., EEG) and/or clinical symptoms who would most benefit from such compounds.

Abstract: Methods, systems, and devices for wireless communications are described. A target user equipment (UE) may receive an indication of a session key from an initiator UE in a sidelink communications system, from a network entity (e.g., a base station), or the like. In some cases, the target UE may also receive an indication of a nonce in a message of a PRS procedure. The target UE may select a positioning reference signal (PRS) sequence for the PRS procedure using the session key and optionally the nonce, such as by using a defined function at the target UE with the session key and the nonce as an input. Once the target UE selects the PRS sequence, the target UE may encode the PRS sequence and may transmit the PRS sequence to the initiator UE.

Abstract: Satellites in a non-terrestrial network may provide positioning reference signals (PRS) to user equipment (UE), with which the UE may determine its position using propagation delay difference measurements, such as Time Difference of Arrival (TDOA) measurement. Due to the large distances between satellites and the UE, the propagation delay differences in the PRS received from satellites may exceed half a radio frame, resulting in a frame level timing ambiguity in the differential measurements. The satellites transmit secondary PRS, along with primary PRS, that include timing information to resolve frame level timing ambiguity of the primary PRS. The positioning occasions in the secondary PRS, for example, may be aligned with corresponding positioning occasions primary PRS within each radio frame, and are transmitted with a periodicity that is an integer multiple (greater than 1) of that of the primary PRS to resolve the frame level timing ambiguity of the primary PRS.

Abstract: A titanium alloy blade tip with a wear-resistant protective coating and a preparation method thereof are provided. The method includes: (1) spraying MCrAlY alloy powder on a surface of a titanium alloy blade tip by high velocity oxygen fuel (HVOF) spraying at a spraying distance of 300-400 mm to obtain the titanium alloy blade tip with a MCrAlY layer on the surface; where M is one of Ni and NiCo; (2) pre-plating Ni at a current density of 4-10 A/dm2; (3) placing the pre-plated titanium alloy blade tip in a Watt solution, covering a surface of the pre-plated titanium alloy blade tip obtained in the step (2) with abrasive particles, and then performing composite electroplating at a current density of 0.5-2 A/dm2. In the method, the wear-resistant protective coating with the high adhesion strength is prepared on the titanium alloy blade tip, and the wear-resistant protective coating has good wear resistance.

Abstract: Some aspects of this disclosure relate to apparatuses and methods for supporting channel state information (CSI) report configuration for network spatial elements adaptation. The UE can receive a CSI report configuration from the base station indicating a first configuration to configure a first CSI report, and a second configuration to configure a second CSI report. The UE can determine one or more active configurations selected from the first configuration and the second configuration, based on whether one or more of the first configuration or the second configuration is activated by a Medium Access Control (MAC) Control Element (MAC CE) or triggered by a Downlink Control Information (DCI). The processor can be further configured to select, based on a report mode, one or more CSI reports from the first CSI report and the second CSI report. The report mode can be a basic mode or an enhanced mode.

Abstract: This disclosure describes, generally, a modified form of CD16, genetically-modified cells that express the modified CD16, and methods that involve the genetically-modified cells. The modified form of CD16 can exhibit increased anti-tumor and/or anti-viral activity due, at least in part, to reduced susceptibility to ADAM17-mediated shedding upon NK cell stimulation.

Abstract: This invention relates to the use of (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone (NSI-189) or a pharmaceutically acceptable salt thereof in the treatment of a psychiatric condition in which depressive symptoms are prominent, including major depressive disorder, bipolar disorder, posttraumatic stress disorder, substance use disorder, and depression-related aspects of schizophrenia (e.g. negative symptoms), in a patient who is cognitively impaired or has poor or slow cognition or difficulty making decisions or exhibits certain EEG properties. The present invention also relates to the selection of patients with a biomarker (e.g., EEG) and/or clinical symptoms who would most benefit from such compounds.

Abstract: This invention relates to the use of (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone (NSI-189) or a pharmaceutically acceptable salt thereof in the treatment of a psychiatric condition in which depressive symptoms are prominent, including major depressive disorder, bipolar disorder, posttraumatic stress disorder, substance use disorder, and depression-related aspects of schizophrenia (e.g. negative symptoms), in a patient who is cognitively impaired or has poor or slow cognition or difficulty making decisions or exhibits certain EEG properties. The present invention also relates to the selection of patients with a biomarker (e.g., EEG) and/or clinical symptoms who would most benefit from such compounds.